Xtant Medical Holdings (FRA:XMS) Cyclically Adjusted FCF per Share: €-2.28 (As of Mar. 2026)


FRA:XMS Xtant Medical Holdings Inc FRA:XMS
27 GF Score
Price €0.36
GF Value €0.57
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Cyclically Adjusted FCF per Share?

Xtant Medical Holdings FRA:XMS +1.12% 27 Cyclically Adjusted FCF per Share is €-2.28 as of Mar. 2026. GuruFocus rates FRA:XMS with a GF Score™ of 27/100 and a GF Value™ of €0.57. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Xtant Medical Holdings's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.014. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-2.28 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 28.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Xtant Medical Holdings was 28.10% per year. The lowest was 14.50% per year. And the median was 21.65% per year.

As of today (2026-07-09), Xtant Medical Holdings's current stock price is €0.36. Xtant Medical Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-2.28. Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF of today is .


Xtant Medical Holdings  (FRA:XMS) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Xtant Medical Holdings Cyclically Adjusted FCF per Share Related Terms


Xtant Medical Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Cyclically Adjusted FCF per Share Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.17 -7.21 -6.11 0.00 -2.46

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.21 -3.12 -2.69 -2.46 -2.28

FRA:XMS vs POSC, LUNG, MDAI: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF falls into.


FRA:XMS
27GF Score
Xtant Medical Holdings Inc FRA:XMS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xtant Medical Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.014/330.2130*330.2130
=-0.014

Current CPI (Mar. 2026) = 330.2130.

Xtant Medical Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -9.135 241.018 -12.516
201609 -4.039 241.428 -5.524
201612 -2.709 241.432 -3.705
201703 0.079 243.801 0.107
201706 -1.144 244.955 -1.542
201709 -0.452 246.819 -0.605
201712 0.256 246.524 0.343
201803 0.011 249.554 0.015
201806 -0.003 251.989 -0.004
201809 -0.074 252.439 -0.097
201812 0.111 251.233 0.146
201903 0.024 254.202 0.031
201906 0.026 256.143 0.034
201909 -0.102 256.759 -0.131
201912 -0.037 256.974 -0.048
202003 -0.141 258.115 -0.180
202006 -0.014 257.797 -0.018
202009 -0.020 260.280 -0.025
202012 0.003 260.474 0.004
202103 -0.019 264.877 -0.024
202106 0.016 271.696 0.019
202109 -0.013 274.310 -0.016
202112 -0.002 278.802 -0.002
202203 -0.015 287.504 -0.017
202206 -0.003 296.311 -0.003
202209 -0.028 296.808 -0.031
202212 -0.024 296.797 -0.027
202303 -0.023 301.836 -0.025
202306 -0.025 305.109 -0.027
202309 -0.028 307.789 -0.030
202312 -0.009 306.746 -0.010
202403 -0.046 312.332 -0.049
202406 -0.040 314.175 -0.042
202409 -0.025 315.301 -0.026
202412 0.000 315.605 0.000
202503 0.001 319.799 0.001
202506 0.005 322.561 0.005
202509 0.024 324.800 0.024
202512 0.028 324.054 0.029
202603 -0.014 330.213 -0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-2.28 mean?
Xtant Medical Holdings (FRA:XMS) has a Cyclically Adjusted FCF per Share of €-2.28 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Xtant Medical Holdings and its competitors.
Is Xtant Medical Holdings' Cyclically Adjusted FCF per Share too high?
Xtant Medical Holdings' current Cyclically Adjusted FCF per Share is €-2.28. Overall, Xtant Medical Holdings has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Cyclically Adjusted FCF per Share compare to POSC and LUNG?
Xtant Medical Holdings' Cyclically Adjusted FCF per Share of €-2.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Xtant Medical Holdings and its competitors. Xtant Medical Holdings's current Cyclically Adjusted FCF per Share is €-2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Xtant Medical Holdings (FRA:XMS) has a current Cyclically Adjusted FCF per Share of €-2.28. The stock's GF Value™ is €0.57, compared to a current price of €0.36 — trading 36.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-2.28. Xtant Medical Holdings' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Xtant Medical Holdings (FRA:XMS), the current Cyclically Adjusted FCF per Share is €-2.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xtant Medical Holdings (FRA:XMS) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of €0.36 is trading 36.8% below its estimated GF Value™ of €0.57.

Key valuation signals for FRA:XMS:

  • Cyclically Adjusted FCF per Share: €-2.28
  • GF Value™: €0.57 vs. price of €0.36 (36.8% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the FRA:XMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Other Exchanges XTNT:USA
Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
27GF Score

Get the complete analysis for FRA:XMS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.36
Price
€0.57
GF Value